This inventor holds 2 USPTO granted patents. Top assignee: Finnish Immunotechnology Ltd.. Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Birmingham, GB (2007)
- Edgbaston, GB (2010)
Company Filing History:
Years Active: 2007-2010
Title: Maria D Lalioti: Innovator in Immunotechnology
Introduction
Maria D Lalioti is a prominent inventor based in Edgbaston, GB. She has made significant contributions to the field of immunotechnology, particularly in the diagnosis and treatment of autoimmune diseases. With a total of 2 patents, her work has garnered attention in the scientific community.
Latest Patents
Maria's latest patents include groundbreaking inventions related to autoimmune polyendocrinopathy syndrome type I (APS I), also known as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). One of her patents focuses on a method for diagnosing diseases related to immune maturation and regulation of immune response. This method involves detecting a specific DNA sequence in biological specimens. Another patent pertains to a novel gene defective in APECED, detailing its diagnostic and therapeutic uses.
Career Highlights
Maria D Lalioti is associated with Finnish Immunotechnology Ltd., where she continues to advance her research and innovations. Her work has been pivotal in understanding the genetic factors contributing to autoimmune diseases, paving the way for new diagnostic and therapeutic approaches.
Collaborations
Maria has collaborated with notable colleagues in her field, including Kai Krohn and Pärt Peterson. These partnerships have enhanced her research and contributed to the development of innovative solutions in immunotechnology.
Conclusion
Maria D Lalioti's contributions to immunotechnology and her innovative patents highlight her role as a leading inventor in the field. Her work continues to impact the diagnosis and treatment of autoimmune diseases, showcasing the importance of research and innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile